HIFRENZO Trademark

Trademark Overview

On Monday, July 1, 2019, a trademark application was filed for HIFRENZO with the United States Patent and Trademark Office. The USPTO has given the HIFRENZO trademark a serial number of 88496083. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 17, 2023. This trademark is owned by AstraZeneca AB. The HIFRENZO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
hifrenzo

General Information

Serial Number88496083
Word MarkHIFRENZO
Filing DateMonday, July 1, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 10, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Monday, April 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 26, 2022SOU EXTENSION 5 GRANTED
Monday, September 12, 2022SOU EXTENSION 5 FILED
Monday, September 26, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 12, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 14, 2022SOU EXTENSION 4 GRANTED
Monday, February 14, 2022SOU EXTENSION 4 FILED
Monday, February 14, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 10, 2021SOU EXTENSION 3 GRANTED
Tuesday, August 10, 2021SOU EXTENSION 3 FILED
Tuesday, August 10, 2021SOU TEAS EXTENSION RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 12, 2021SOU EXTENSION 2 GRANTED
Friday, February 12, 2021SOU EXTENSION 2 FILED
Friday, February 12, 2021SOU TEAS EXTENSION RECEIVED
Thursday, August 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 18, 2020SOU EXTENSION 1 GRANTED
Tuesday, August 18, 2020SOU EXTENSION 1 FILED
Tuesday, August 18, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, March 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 18, 2019ASSIGNED TO LIE
Monday, December 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 25, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 25, 2019NON-FINAL ACTION E-MAILED
Wednesday, September 25, 2019NON-FINAL ACTION WRITTEN
Thursday, September 19, 2019ASSIGNED TO EXAMINER
Thursday, August 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 4, 2019NEW APPLICATION ENTERED

Related Keywords

hifrenzo disorders diseases pharmaceutical anemia substances preparations nervous system inflammation infection